Driesen Bart W, Warmerdam Evangeline G, Sieswerda Gert-Jan, Meijboom Folkert J, Molenschot Mirella M C, Doevendans Pieter A, Krings Gregor J, van Dijk Arie P J, Voskuil Michiel
Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
Department of Cardiology, Radboudumc, Nijmegen, Netherlands.
Curr Cardiol Rev. 2019;15(4):262-273. doi: 10.2174/1573403X15666181224113855.
Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.
大多数患有先天性心脏病(CHD)且右心室流出道(RVOT)功能障碍的患者一生中需要多次进行肺动脉瓣置换。自2000年经皮肺动脉瓣植入术(PPVI)问世以来,其数量不断增长,在全球范围内已超过10000例手术。总体而言,PPVI已被证明是安全有效的,但一些解剖变异可能会限制手术的成功率。本文综述了该手术的现状和未来展望。